Edwards Lifesciences (EW) Long-Term Debt Repayments (2009 - 2022)

Edwards Lifesciences has reported Long-Term Debt Repayments for 12 years, with the latest figure at $100000.0 in Q4 2022.

• For the quarter ending Q4 2022, Long-Term Debt Repayments changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Dec 2022 stood at $200000.0 (down 97.14% YoY), and the FY2023 full-year result was $300000.0, up 50.0% from the prior year.
• Long-Term Debt Repayments for Q4 2022 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
• The five-year high for Long-Term Debt Repayments was $601.2 million in Q4 2018, with the low at -$8.7 million in Q3 2021.
• Average Long-Term Debt Repayments over 5 years is $65.5 million, with a median of $3.8 million recorded in 2019.
• Year-over-year, Long-Term Debt Repayments jumped 10635.71% in 2018 and sank 495.45% in 2021.
• Tracing EW's Long-Term Debt Repayments over 5 years: stood at $601.2 million in 2018, then slumped by 99.14% to $5.2 million in 2019, then sank by 42.31% to $3.0 million in 2020, then slumped by 96.67% to $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022.
• The last three Long-Term Debt Repayments figures came in at $100000.0 (Q4 2022), $100000.0 (Q2 2022), and $100000.0 (Q4 2021), per Business Quant data.

Peer Comparison